Ingrid Louise Titlestad

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim Harrison, Pascal Chanez, Francesco Menzella et al. · The Lancet Respiratory Medicine · 2020 · 168 citations · Full text

Asthma, Severe Eosinophilic Asthma, Allergy +10

Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial

Richard Russell, Latifa Chachi, J. Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 130 citations · Full text

Inflammation, Asthma, Placebo-controlled Phase 2 +10

Leukocyte-depletion of blood components does not significantly reduce the risk of infectious complications

Ingrid Louise Titlestad, Liselotte S. Ebbesen, Alan Patrick Ainsworth et al. · International Journal of Colorectal Disease · 2001 · 93 citations

Granulocyte, Blood Components, Transfusion Medicine +8

Effects of an oral MMP-9 and -12 inhibitor, AZD1236, on biomarkers in moderate/severe COPD: A randomised controlled trial

Ronald Dahl, Ingrid Louise Titlestad, Ari Lindqvist et al. · Pulmonary Pharmacology & Therapeutics · 2012 · 81 citations

Inflammation, Oral Mmp-9, Allergy +9

Surgical treatment versus conventional chest tube drainage in primary spontaneous pneumothorax: a randomized controlled trial†

Winnie Hedevang Olesen, Niels Katballe, Jesper Eske Sindby et al. · European Journal of Cardio-Thoracic Surgery · 2018 · 76 citations · Full text